The US Health Care Market In Transition For Medtechs
As US providers and medtech manufacturers boldly go into the new outcomes-based world, they do so against the backdrop of a medtech industry that is undergoing its own changes.
You may also be interested in...
2016 was a year of surprise and change in political circles, but that's nothing new for the medtech industry, which over a number of years has become accustomed to health care systems demanding different and ever-higher levels of service. Smart medtechs have been ahead of the curve, but the whole industry now factors in clients' wider needs in a holistic approach to patient care. Many companies' current M&A policies are already reflecting the changes to come.
US hospitals have suddenly started to care economically about the episodes of care that patients receive – an adjustment that requires medtech companies to adapt accordingly. So says ZS Associates in a new report about how companies need to work in step with providers as the transition to outcomes-based care accelerates.
BVMed says the EU and the UK should set up a system of mutual recognition of medical device regulation to kick in when the UK’s EU exit transition period ends on 31 December.